Northzone

Dynamk Capital is an early stage Life Sciences investor and partner that looks to accelerate the growth and adoption of disruptive solutions and services. We are committed to advancing novel technologies for human health. We are passionate about creating the future of biotech and life sciences. We believe innovative services, tools and technologies are critical to enabling the discovery, development and production of life-saving therapies, delivering lower costs, and increasing access to medicines globally. Life science entrepreneurs with highly disruptive, market-defining ideas have long struggled to secure the right mix of capital and expertise. Dynamk addresses this gap with deep domain and technical expertise, coupled with the strategic and commercialization experience to help these companies realize full potential.

EQT Ventures is the venture capital arm of EQT, investing in high-growth technology companies across Europe and the US.

K2 Global is a venture capital firm focused on private companies. We invest from seed to growth in Internet, software and technology-enabled companies.

Andreessen Horowitz backs bold entrepreneurs who move fast, think big, and are committed to building the next major franchises in technology. Founded by Marc Andreessen and Ben Horowitz, the firm provides entrepreneurs with access to expertise and insights in innovation, executive and technical talent, market intelligence, policy and regulatory affairs, business development, and marketing and brand-building.

Union Square Ventures is a small collegial partnership based in New York that manages over $1B across seven technology-focused venture funds. Union Square Ventures is one of the most successful venture funds in the world and has been an early-stage investor in some of America's most successful startups such as Zynga, Indeed, Tumblr, Twitter, Lending Club, Etsy, Twilio and MongoDB. USV was founded in 2003 by Fred Wilson and Brad Burnham.

GV (formerly Google Ventures) is the venture capital arm of Google (Alphabet, Inc.). GV has been investing in technology and biotechnology related companies in the life science, healthcare, artificial intelligence, robotics, transportation, cyber security, and agriculture sectors. We have a world-class team of engineers, designers, physicians, scientists, marketers, and investors who work together to provide these startups exceptional support on the road to success. We help our companies interface with Google, providing unique access to the world's best technology and talent. That said, we operate as an independent venture firm that is focused on investment returns. Today, GV has approximately $2.4bn in assets under management and looks to invest $500m per year in start ups. GV is separate to Capital G (formerly Google Capital), which invests in fewer, more mature ventures, with larger deal sizes.